1.01 USD
↗ 0.05 (5.19%)LIVE (AS OF 10:04 AM EDT)
Outlook Therapeutics, Inc. Common Stock
OTLKNASDAQ • USD
Market: OPEN
Outlook Therapeutics, Inc. Common Stock (OTLK) is currently trading at $1.01. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (164.4%) and a bullish Golden Cross on the moving averages. On the valuation front, OTLK trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 4, 2026.
Open?$0.95
High?$1.02
Low?$0.93
Prev. Close?$0.96
Volume?1.2M
Avg. Volume?12.9M
VWAP?$0.99
Rel. Volume?0.10x
Bid / Ask
Bid?$0.87 × 100
Ask?$1.01 × 200
Spread?$0.14
Midpoint?$0.94
Valuation & Ratios
Market Cap?179.5M
Shares Out?187.0M
Float?83.0M
Float %?99.9%
P/E Ratio?N/A
P/B Ratio?-6.19
EPS?-$0.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
Employees
17
Market Cap
170.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2016-05-13
Address
111 S. WOOD AVENUE
ISELIN, NJ 08830
Phone: (609) 619-3990
ISELIN, NJ 08830
Phone: (609) 619-3990
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-45.86Distress
Confidence?45%Low
Short InterestHigh
Short % of Float?13.54%High
Short Interest?11.2M
Days to Cover?1.2
Free Float83.0M
Avg Daily Volume9.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?0.54Weak
Quick Ratio?0.45Weak
Cash Ratio?0.20Low
Debt/Equity?-0.93Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-6.19CHEAP▾
S&P97
P/S?422.46HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
S&P97
EV/Sales?467.70HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?164.4%STRONG▾
Peers50
S&P97
ROA?-217.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$198.7M
Fundamentals ratios updated end of day